This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

 
 

News

  • Impact NKI research highlighted by ASCO

    Research led by Lisette Rozeman was selected by the American Society of Clinical Oncology for inclusion in the Clinical Cancer Advances 2020, which highlights the most impactful research advances of the past year.

    Read More
  • High-dose chemotherapy in high-risk breast cancer shows improved survival in 20-year follow-up

    A follow-up study after 20 years shows that the survival rate for women with breast cancer and ten or more affected lymph nodes in the armpit is 15% higher after high-dose chemotherapy than after the conventional dose. Moreover, the patients did not show an increase in secondary cancers or serious cardiovascular diseases. The follow-up study, coordinated by Tessa Steenbruggen (Netherlands Cancer Institute) and Lars Steggink (UMCG), was published in JAMA Oncology at January 30.

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us